Grove Bank & Trust Amgen Inc Transaction History

Grove Bank & Trust

$593 Million
Q1 2024

A detailed history of Grove Bank & Trust transactions in Amgen Inc stock. As of the latest transaction made, Grove Bank & Trust holds 2,677 shares of AMGN stock, worth $861,110. This represents 0.13% of its overall portfolio holdings.

Number of Shares

2,677

Previous 4,749 43.63%

Holding current value

$861,110

Previous $1.37 Million 44.33%

% of portfolio

0.13%

Previous 0.25%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$268.87 - $324.56 $557,098 - $672,488	-2,072 Reduced 43.63%	2,677 $761,000
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $366,673 - $413,651	-1,434 Reduced 23.19%	4,749 $1.37 Million
Q3 2023 Oct 30, 2023	BUY	$218.65 - $271.46 $131,845 - $163,690	603 Added 10.81%	6,183 $1.66 Million
Q2 2023 Jul 27, 2023	BUY	$214.27 - $253.37 $217,698 - $257,423	1,016 Added 22.26%	5,580 $1.24 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $129,603 - $157,964	574 Added 14.39%	4,564 $1.1 Million

Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $181,391 - $230,479	-792 Reduced 16.56%	3,990 $1.05 Million
Q3 2022 Oct 28, 2022	BUY	$224.46 - $253.15 $136,471 - $153,915	608 Added 14.57%	4,782 $1.08 Million
Q2 2022 Jul 29, 2022	BUY	$230.71 - $256.74 $26,993 - $30,038	117 Added 2.88%	4,174 $1.02 Million
Q1 2022 Apr 22, 2022	BUY	$219.27 - $242.57 $143,841 - $159,125	656 Added 19.29%	4,057 $981,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $42,759 - $48,934	215 Added 6.75%	3,401 $765,000
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $10,401 - $12,186	-49 Reduced 1.51%	3,186 $678,000
Q2 2021 Jul 28, 2021	BUY	$233.58 - $259.14 $14,715 - $16,325	63 Added 1.99%	3,235 $789,000
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $1,775 - $2,068	8 Added 0.25%	3,172 $789,000
Q4 2020 Feb 03, 2021	BUY	$216.38 - $257.67 $28,778 - $34,270	133 Added 4.39%	3,164 $727,000
Q3 2020 Oct 30, 2020	SELL	$234.65 - $260.95 $13,140 - $14,613	-56 Reduced 1.81%	3,031 $770,000
Q2 2020 Jul 31, 2020	BUY	$197.81 - $242.74 $77,739 - $95,396	393 Added 14.59%	3,087 $728,000
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $2,186 - $2,900	-12 Reduced 0.44%	2,694 $546,000
Q4 2019 Feb 11, 2020	BUY	$189.21 - $243.2 $39,734 - $51,072	210 Added 8.41%	2,706 $652,000
Q3 2019 Oct 30, 2019	BUY	$174.11 - $208.62 $49,273 - $59,039	283 Added 12.79%	2,496 $483,000
Q2 2019 Jul 24, 2019	SELL	$166.7 - $195.41 $1,667 - $1,954	-10 Reduced 0.45%	2,213 $408,000
Q1 2019 Apr 26, 2019	BUY	$180.87 - $203.88 $71,443 - $80,532	395 Added 21.61%	2,223 $422,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $36,928 - $43,107	207 Added 12.77%	1,828 $356,000
Q3 2018 Nov 07, 2018	SELL	$185.29 - $208.89 $19,826 - $22,351	-107 Reduced 6.19%	1,621 $336,000
Q2 2018 Aug 03, 2018	SELL	$166.05 - $186.51 $5,479 - $6,154	-33 Reduced 1.87%	1,728 $319,000
Q1 2018 May 07, 2018	SELL	$169.43 - $198.0 $7,285 - $8,514	-43 Reduced 2.38%	1,761 $300,000
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $5,570 - $6,223	33 Added 1.86%	1,804 $314,000
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $296,270 - $338,261	1,771	1,771 $330,000

Others Institutions Holding AMGN

# of Institutions

2,939

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.

Account